Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Argan (AGX) EBITDA (2016 - 2025)

Argan's EBITDA history spans 16 years, with the latest figure at $32.2 million for Q4 2025.

  • For Q4 2025, EBITDA rose 21.99% year-over-year to $32.2 million; the TTM value through Oct 2025 reached $125.5 million, up 92.93%, while the annual FY2025 figure was $82.5 million, 160.83% up from the prior year.
  • EBITDA for Q4 2025 was $32.2 million at Argan, down from $33.9 million in the prior quarter.
  • Across five years, EBITDA topped out at $33.9 million in Q3 2025 and bottomed at $1.6 million in Q1 2022.
  • The 5-year median for EBITDA is $11.9 million (2021), against an average of $14.4 million.
  • The largest annual shift saw EBITDA skyrocketed 1155.3% in 2021 before it crashed 84.63% in 2022.
  • A 5-year view of EBITDA shows it stood at $11.9 million in 2021, then tumbled by 40.38% to $7.1 million in 2022, then tumbled by 41.54% to $4.2 million in 2023, then soared by 535.23% to $26.4 million in 2024, then increased by 21.99% to $32.2 million in 2025.
  • Per Business Quant, the three most recent readings for AGX's EBITDA are $32.2 million (Q4 2025), $33.9 million (Q3 2025), and $28.9 million (Q2 2025).